X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (77) 77
humans (57) 57
infectious diseases (44) 44
mortality (36) 36
microbiology (34) 34
female (24) 24
male (24) 24
antibiotics (23) 23
aged (21) 21
anti-bacterial agents - therapeutic use (21) 21
infections (20) 20
randomized controlled trials as topic (20) 20
risk factors (18) 18
treatment outcome (18) 18
bacteremia (17) 17
middle aged (17) 17
medicine, general & internal (16) 16
therapy (16) 16
pharmacology & pharmacy (14) 14
immunology (13) 13
retrospective studies (13) 13
adult (12) 12
aged, 80 and over (12) 12
analysis (12) 12
clinical trials (11) 11
health aspects (11) 11
patients (10) 10
anti-bacterial agents - adverse effects (9) 9
bacteria (9) 9
diagnosis (9) 9
infection (9) 9
sepsis (9) 9
care and treatment (8) 8
epidemiology (8) 8
internal medicine (8) 8
israel - epidemiology (8) 8
management (8) 8
research (8) 8
risk-factors (8) 8
systematic review (8) 8
vancomycin (8) 8
abridged index medicus (7) 7
cephalosporins - therapeutic use (7) 7
fever (7) 7
impact (7) 7
medical research (7) 7
medicine, experimental (7) 7
pathogens (7) 7
adolescent (6) 6
anti-bacterial agents - administration & dosage (6) 6
bacteremia - microbiology (6) 6
bacterial infections (6) 6
blood-stream infections (6) 6
child (6) 6
child, preschool (6) 6
cohort studies (6) 6
colistin (6) 6
efficacy (6) 6
gram-negative bacteria (6) 6
infectious disease (6) 6
medical microbiology (6) 6
meropenem (6) 6
outcomes (6) 6
staphylococcal infections - drug therapy (6) 6
bacteremia - drug therapy (5) 5
bacteremia - epidemiology (5) 5
bacteremia - mortality (5) 5
bacterial infections - drug therapy (5) 5
bacterial infections - mortality (5) 5
biomedicine (5) 5
combination therapy (5) 5
complications (5) 5
double-blind (5) 5
drug resistance, bacterial (5) 5
drug therapy (5) 5
hemodialysis (5) 5
israel (5) 5
medicine general & introductory medical sciences (5) 5
methicillin-resistant staphylococcus aureus (5) 5
piperacillin-tazobactam (5) 5
pneumonia (5) 5
prophylaxis (5) 5
staphylococcal infections - microbiology (5) 5
staphylococcus aureus (5) 5
surgery (5) 5
time (5) 5
urinary tract infections (5) 5
usage (5) 5
vancomycin - therapeutic use (5) 5
acinetobacter (4) 4
beta-lactams - therapeutic use (4) 4
case-control studies (4) 4
clinical outcomes (4) 4
confidence intervals (4) 4
cotrimoxazole (4) 4
drug resistance (4) 4
drug resistance in microorganisms (4) 4
drug therapy, combination (4) 4
elderly (4) 4
endemic diseases (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Catheterization and cardiovascular interventions, ISSN 1522-1946, 2018, Volume 92, Issue 2, pp. 408 - 416
Background Although transcatheter aortic valve replacement (TAVR) is officially indicated for high risk aortic stenosis (AS) patients, the procedure is... 
transcatheter aortic valve replacement | surgical aortic valve replacement | surgical risk category | MORTALITY | CARDIAC & CARDIOVASCULAR SYSTEMS | STENOSIS | IMPLANTATION | INTERMEDIATE | OUTCOMES | Heart Valve Prosthesis Implantation - instrumentation | Humans | Male | Aortic Valve - surgery | Recovery of Function | Aortic Valve Stenosis - diagnostic imaging | Aortic Valve Stenosis - mortality | Patient Selection | Clinical Decision-Making | Aged, 80 and over | Observational Studies as Topic | Female | Aortic Valve Stenosis - surgery | Transcatheter Aortic Valve Replacement - adverse effects | Transcatheter Aortic Valve Replacement - instrumentation | Aortic Valve - diagnostic imaging | Risk Assessment | Heart Valve Prosthesis | Risk Factors | Aortic Valve Stenosis - physiopathology | Aortic Valve - physiopathology | Heart Valve Prosthesis Implantation - mortality | Treatment Outcome | Randomized Controlled Trials as Topic | Propensity Score | Heart Valve Prosthesis Implantation - adverse effects | Aged | Hemodynamics | Transcatheter Aortic Valve Replacement - mortality | Medicine, Experimental | Medical research | Health aspects | Aortic valve stenosis | Mortality | Myocardial infarction | Cerebral infarction | Stroke | Complications | Clinical trials | Stenosis | Risk reduction | Implantation | Risk analysis | Patients | Bleeding | Randomization | Surgery | Renal failure | Aorta | Infarction | Aortic valve
Journal Article
Trials, ISSN 1745-6215, 2016, Volume 17, Issue 1, p. 170
....7,8], Mark Chatfield[sup.1], Jeffrey Lipman[sup.9,10], Sebastian Van Hal[sup.11], Matthew O'Sullivan[sup.12,13], James O. Robinson[sup.14,15], Dafna Yahav[sup... 
Flucloxacillin | Cefazolin | Methicillin-resistant | Combination | Daptomycin | MRSA | Randomised controlled trial | Vancomycin | Cloxacillin | Staphylococcus aureus | Nafcillin | UNITED-STATES | MEDICINE, RESEARCH & EXPERIMENTAL | ACUTE KIDNEY INJURY | VITRO PHARMACOKINETIC/PHARMACODYNAMIC MODEL | PIPERACILLIN-TAZOBACTAM | INTRAVENOUS-DRUG-USERS | EMPIRICAL-THERAPY | IN-VITRO | ANTIBACTERIAL ACTIVITY | PLUS CEFTAROLINE | BETA-LACTAMS | Singapore | Humans | Clinical Protocols | Anti-Bacterial Agents - therapeutic use | Methicillin-Resistant Staphylococcus aureus - pathogenicity | Time Factors | Anti-Bacterial Agents - adverse effects | Staphylococcal Infections - microbiology | Drug Therapy, Combination | Methicillin Resistance | Cloxacillin - therapeutic use | Daptomycin - therapeutic use | Staphylococcal Infections - drug therapy | Cefazolin - therapeutic use | Methicillin-Resistant Staphylococcus aureus - drug effects | Treatment Outcome | Floxacillin - therapeutic use | New Zealand | Staphylococcal Infections - diagnosis | Vancomycin - therapeutic use | beta-Lactams - adverse effects | Israel | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Australia | beta-Lactams - therapeutic use | Research Design | Prevention | Drug resistance in microorganisms | Care and treatment | Analysis | Staphylococcus aureus infections | Clinical trials | Development and progression | Beta lactamases | Research | Health aspects
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2009, Volume 9, Issue 1, pp. 6 - 7
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 12/2011, Volume 66, Issue 12, pp. 2895 - 2896
Journal Article
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 01/2020, Volume 70, Issue 2, pp. 351 - 353
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 09/2019, Volume 69, Issue 7, pp. 1263 - 1264
Journal Article
Aging clinical and experimental research, ISSN 1720-8319, 2019
...: what is the real goal? Yaara Leibovici‑Weissman1,2 · Noam Tau1,3 · Dafna Yahav1,4 Received: 8 April 2019 / Accepted: 22 August 2019 © Springer Nature Switzerland AG 2019... 
Journal Article
Obstetrical & Gynecological Survey, ISSN 0029-7828, 08/2018, Volume 73, Issue 8, pp. 456 - 457
(Abstracted from JAMA 2018;319:1781–1789)Guidelines for the treatment of uncomplicated lower urinary tract infections (UTIs) were modified in 2010 because of... 
OBSTETRICS & GYNECOLOGY | Women | Treatment outcome | Nitrofurantoin | Analysis | Urinary tract infections | Dosage and administration | Research | Comparative analysis | Drug therapy | Health aspects | Fosfomycin
Journal Article
European journal of clinical microbiology & infectious diseases, ISSN 1435-4373, 2019, Volume 38, Issue 7, pp. 1313 - 1318
Journal Article
Journal Article